Atlas FDA

OQI

5 FDA 510(k) clearances · Product code

263 daysmedian time to decision
370 days90th percentile
5clearances measured

FDA profile

Official device name
Hip, Semi-Constrained, Cemented, Metal/Ceramic/Polymer + Additive, Porous Uncemented
Device class
Class II (moderate risk)
Regulation
21 CFR 888.3353
Medical specialty
Orthopedic
Flags
Implant
FDA definition
1. Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis. 2. Rheumatoid arthritis. 3. Correction of functional deformity. 4. Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques. 5. Revision procedures where other treatment or devices have failed. Cemented and uncemented use.
Adverse events (MAUDE)
2015: 9 · 2016: 17 · 2023: 23 · 2024: 35 · 2025: 45 · 2026: 14
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
EPORE® XO cup system (K252451)Implantcast GmbH2026-04-24
Libertas E-XLPE Modular Liner (K192989)Maxx Orthopedics, Inc.2020-10-29
E-XPE Acetabular Components and U-Motion II Acetabular Cup (K172833)United Orthopedic Corporation2018-06-12
Exactech® Novation® and AcuMatch® E-HXL Acetabular Liners (K173583)Exactech, Inc.2018-03-12
CORIN TRINITY ACETABULAR SYSTEM ECIMA LINERS (K111481)Corin USA2012-02-06

Track OQI automatically

Every clearance here is in the API, with alerts when new ones post.